Obese breast cancer patients with BMI ≥35 kg/m2, in particular postmenopausal women, demonstrate significantly higher hazard ratios for the development of hormone receptor positive (ER+/PR+) breast cancer, with larger tumors and more advanced disease (37, 39). Here, NR4A1 is linked to breast cancer.